Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

FDA issues approvable letter for Visudyne

Feb. 14, 2000

New ophthalmic gene licensed by InSite

Feb. 10, 2000

Oculex updates intraocular drug delivery pipeline

Feb. 4, 2000

Visudyne market introduction announced

Feb. 2, 2000

Are cannabinoid receptors involved in the IOP-lowering effects of cannabinoids?

Feb. 2, 2000

InSite Vision licenses novel TIGR modifier gene

Feb. 2, 2000

Alcon makes milestone payment to Pharmacyclics for Optrin

Feb. 1, 2000

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Jan. 19, 2000

Pharmacia & Upjohn seeks approval for combination glaucoma therapy

Jan. 11, 2000

Inspire's dry eye product enters phase II testing

Jan. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...